Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Investigation of wholebody MRI and circulating biomarkers of inflammation, cartilage and bone metabolism in patients with spondyloarthritis treated with adalimumab. Furthermore to compare ultrasound examination with wholebody MRI etc.
Epistemonikos ID: af5c0bf91b1cf0c39c583d025049d6977a17ea86
First added on: May 05, 2024